These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2686610

  • 1. A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin.
    Gibson J, Date L, Joshua DE, Young GA, Wilson A, Benn R, Benson W, Iland H, Vincent PC, Kronenberg H.
    Aust N Z J Med; 1989 Oct; 19(5):417-25. PubMed ID: 2686610
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases.
    Gibson J, Johnson L, Snowdon L, Joshua D, Young G, MacLeod C, Iland H, Vincent P, Kronenberg H.
    Int J Hematol; 1994 Aug; 60(2):119-27. PubMed ID: 7948961
    [Abstract] [Full Text] [Related]

  • 4. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S, Raccah R, Santilli S, Micozzi A, Girmena C, Martino P, Avvisati G.
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gram-positive bacteraemia in granulocytopenic cancer patients.
    EORTC International Antimicrobial Therapy Cooperative GroupDepartment of Infectious Disease, G. Gaslini Scientific Institute, University of Genova, Italy..
    Eur J Cancer; 1990 Oct; 26(5):569-74. PubMed ID: 2144743
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
    Menichetti F, Martino P, Bucaneve G, Gentile G, D'Antonio D, Liso V, Ricci P, Nosari AM, Buelli M, Carotenuto M.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2041-6. PubMed ID: 7811016
    [Abstract] [Full Text] [Related]

  • 13. Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study.
    Erman M, Akova M, Akan H, Korten V, Ferhanoğlu B, Köksal I, Cetinkaya Y, Uzun O, Unal S, Febrile Neutropenia Study Group of Turkey.
    Scand J Infect Dis; 2001 Sep; 33(11):827-31. PubMed ID: 11760163
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomised comparison of ceftazidime and piperacillin, both in combination with flucloxacillin for treatment of febrile episodes in neutropenic children. Finnish Three-Centre Study.
    Perkkiö M, Hovi L, Rajantie J, Lanning M, Salmi T, Williams K, Mäkipernaa A, Ruuskanen O, Renkonen OV, Herva E.
    Scand J Infect Dis; 1990 Sep; 22(2):209-18. PubMed ID: 2192440
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
    Nucci M, Biasoli I, Braggio S, Portugal R, Schaffel R, Maiolino A, Loureiro MM, Spector N, Pulcheri W.
    Oncol Rep; 1998 Sep; 5(5):1205-9. PubMed ID: 9683836
    [Abstract] [Full Text] [Related]

  • 18. Ceftriaxone plus conventional or single-daily dose amikacin versus ceftazidime/amikacin as empiric therapy in febrile neutropenic patients.
    Leoni F, Ciolli S, Pascarella A, Fanci R, Caporale R, Rossi Ferrini P.
    Chemotherapy; 1993 Sep; 39(2):147-52. PubMed ID: 8458248
    [Abstract] [Full Text] [Related]

  • 19. A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients.
    de Pauw B, Williams K, de Neeff J, Bothof T, de Witte T, Holdrinet R, Haanen C.
    Antimicrob Agents Chemother; 1985 Dec; 28(6):824-8. PubMed ID: 3909956
    [Abstract] [Full Text] [Related]

  • 20. Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever.
    Engervall P, Günther G, Ljungman P, Lönnqvist B, Hast R, Stiernstedt G, Kalin M, Ringertz S, Bjökholm M.
    Scand J Infect Dis; 1996 Dec; 28(3):297-303. PubMed ID: 8863366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.